All Stories

  1. Identification and quantification of glucose degradation products in heat-sterilized glucose solutions for parenteral use by thin-layer chromatography

    Article • PLoS ONE, July 2021, PLOS

    Dr. Martin M. Brandl

  2. Co-existing colloidal phases in artificial intestinal fluids assessed by AF4/MALLS and DLS: A systematic study into cholate & (lyso-) phospholipid blends, incorporating celecoxib as a model drug

    Article • European Journal of Pharmaceutical Sciences, April 2018, Elsevier

    Dr. Martin M. Brandl

  3. PermeaLoop™, a novel in vitro tool for small-scale drug-dissolution/permeation studies

    Article • Journal of Pharmaceutical and Biomedical Analysis, April 2018, Elsevier

    Dr. Martin M. Brandl

  4. Archaeal lipids in oral delivery of therapeutic peptides

    Article • European Journal of Pharmaceutical Sciences, October 2017, Elsevier

    Dr. Martin M. Brandl

  5. Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate

    Article • European Journal of Pharmaceutical Sciences, January 2017, Elsevier

    Dr. Martin M. Brandl

  6. A novel microdialysis-dissolution/permeation system for testing oral dosage forms: A proof-of-concept study

    Article • European Journal of Pharmaceutical Sciences, January 2017, Elsevier

    Dr. Martin M. Brandl

  7. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release−/transfer-assay

    Article • Journal of Controlled Release, June 2016, Elsevier

    Dr. Martin M. Brandl

  8. The use of asymmetrical flow field-flow fractionation with on-line detection in the study of drug retention within liposomal nanocarriers and drug transfer kinetics

    Article • Journal of Pharmaceutical and Biomedical Analysis, May 2016, Elsevier

    Dr. Martin M. Brandl

  9. A new approach for a blood-brain barrier model based on phospholipid vesicles: Membrane development and siRNA-loaded nanoparticles permeability

    Article • Journal of Membrane Science, April 2016, Elsevier

    Dr. Martin M. Brandl

  10. Solid Phospholipid Dispersions for Oral Delivery of Poorly Soluble Drugs: Investigation Into Celecoxib Incorporation and Solubility-In Vitro Permeability Enhancement

    Article • Journal of Pharmaceutical Sciences, March 2016, Elsevier

    Dr. Martin M. Brandl

  11. Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis

    Article • European Journal of Pharmaceutical Sciences, December 2015, Elsevier

    Dr. Martin M. Brandl

  12. Filter-extruded liposomes revisited: a study into size distributions and morphologies in relation to lipid-composition and process parameters

    Article • Journal of Liposome Research, September 2015, Taylor & Francis

    Dr. Martin M. Brandl

  13. Liposomes containing lipids from Sulfolobus islandicus withstand intestinal bile salts: An approach for oral drug delivery?

    Article • International Journal of Pharmaceutics, September 2015, Elsevier

    Dr. Martin M. Brandl

  14. The Effects of Temperature and Growth Phase on the Lipidomes of Sulfolobus islandicus and Sulfolobus tokodaii

    Article • Life, August 2015, MDPI AG

    Dr. Martin M. Brandl

  15. Structural characterization of ether lipids from the archaeonSulfolobus islandicusby high-resolution shotgun lipidomics

    Article • Journal of Mass Spectrometry, February 2015, Wiley

    Dr. Martin M. Brandl

  16. What Is the Mechanism Behind Increased Permeation Rate of a Poorly Soluble Drug from Aqueous Dispersions of an Amorphous Solid Dispersion?

    Article • Journal of Pharmaceutical Sciences, June 2014, Elsevier

    Dr. Martin M. Brandl

  17. Multifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochloride

    Article • Journal of Liposome Research, May 2014, Taylor & Francis

    Dr. Martin M. Brandl

  18. Asymmetrical flow field-flow fractionation with on-line detection for drug transfer studies: a feasibility study

    Article • Analytical and Bioanalytical Chemistry, February 2014, Springer Science + Business Media

    Dr. Martin M. Brandl

  19. Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”

    Article • European Journal of Pharmaceutical Sciences, September 2013, Elsevier

    Dr. Martin M. Brandl

  20. Physicochemical characterization of liposomes after ultrasound exposure – Mechanisms of drug release

    Article • Journal of Pharmaceutical and Biomedical Analysis, May 2013, Elsevier

    Dr. Martin M. Brandl

  21. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution

    Article • Journal of Liposome Research, December 2012, Taylor & Francis

    Dr. Martin M. Brandl

  22. Brain delivery of camptothecin by means of solid lipid nanoparticles: Formulation design, in vitro and in vivo studies

    Article • International Journal of Pharmaceutics, December 2012, Elsevier

    Dr Eliana B. Souto, Dr. Martin M. Brandl, Professor Ingunn Tho

  23. The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility

    Article • International Journal of Nanomedicine, November 2012, Taylor & Francis

    Dr. Martin M. Brandl

  24. Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: True supersaturation vs. apparent solubility enhancement

    Article • International Journal of Pharmaceutics, November 2012, Elsevier

    Dr. Martin M. Brandl

  25. Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound

    Article • European Journal of Pharmaceutical Sciences, August 2012, Elsevier

    Dr. Martin M. Brandl

  26. Oral bioavailability of ketoprofen in suspension and solution formulations in rats: the influence of poloxamer 188

    Article • Journal of Pharmacy and Pharmacology, June 2012, Wiley

    Dr. Martin M. Brandl

  27. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles

    Article • European Journal of Pharmaceutical Sciences, April 2012, Elsevier

    Dr Eliana B. Souto, Dr. Martin M. Brandl, Professor Ingunn Tho

  28. In vitro models to evaluate the permeability of poorly soluble drug entities: Challenges and perspectives

    Article • European Journal of Pharmaceutical Sciences, February 2012, Elsevier

    Dr. Martin M. Brandl

  29. Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay

    Article • International Journal of Pharmaceutics, January 2012, Elsevier

    Dr. Martin M. Brandl

  30. Relative Spatial Positions of Tryptophan and Cationic Residues in Helical Membrane-active Peptides Determine Their Cytotoxicity

    Article • Journal of Biological Chemistry, November 2011, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr. Martin M. Brandl

  31. Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2011, Elsevier

    Dr. Martin M. Brandl

  32. Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin

    Article • European Journal of Pharmaceutical Sciences, July 2011, Elsevier

    Dr. Martin M. Brandl

  33. Compressibility study of quaternary phospholipid blend monolayers

    Article • Colloids and Surfaces B Biointerfaces, July 2011, Elsevier

    Dr. Martin M. Brandl, Professor Ingunn Tho

  34. In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants

    Article • Journal of Pharmacy and Pharmacology, June 2011, Wiley

    Dr. Martin M. Brandl

  35. Solubilization of ibuprofen with β-cyclodextrin derivatives: Energetic and structural studies

    Article • Journal of Pharmaceutical and Biomedical Analysis, June 2011, Elsevier

    Dr. Martin M. Brandl

  36. Lipid membrane composition influences drug release from dioleoylphosphatidylethanolamine-based liposomes on exposure to ultrasound

    Article • International Journal of Pharmaceutics, March 2011, Elsevier

    Dr. Martin M. Brandl

  37. Ultrasound-mediated destabilization and drug release from liposomes comprising dioleoylphosphatidylethanolamine

    Article • European Journal of Pharmaceutical Sciences, March 2011, Elsevier

    Dr. Martin M. Brandl

  38. Liposomal solubilization of new 3-hydroxy-quinolinone derivatives with promising anticancer activity: a screening method to identify maximum incorporation capacity

    Article • Journal of Liposome Research, February 2011, Taylor & Francis

    Dr. Martin M. Brandl

  39. Physicochemical properties of lipid nanoparticles: Effect of lipid and surfactant composition

    Article • Drug Development and Industrial Pharmacy, January 2011, Taylor & Francis

    Dr. Martin M. Brandl, Professor Ingunn Tho

  40. In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation

    Article • Journal of Pharmaceutical and Biomedical Analysis, November 2010, Elsevier

    Dr. Martin M. Brandl, Professor Ingunn Tho

  41. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier

    Article • Journal of Pharmacy and Pharmacology, October 2010, Wiley

    Dr. Martin M. Brandl, Professor Ingunn Tho

  42. Distearoylphosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery

    Article • European Journal of Pharmaceutics and Biopharmaceutics, August 2010, Elsevier

    Dr. Martin M. Brandl

  43. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media

    Article • European Journal of Pharmaceutical Sciences, April 2010, Elsevier

    Dr. Martin M. Brandl, Professor Ingunn Tho

  44. Vesicular phospholipid gel-based depot formulations for pharmaceutical proteins: Development and in vitro evaluation

    Article • Journal of Controlled Release, March 2010, Elsevier

    Dr. Martin M. Brandl

  45. Liposome fractionation and size analysis by asymmetrical flow field-flow fractionation/multi-angle light scattering: influence of ionic strength and osmotic pressure of the carrier liquid

    Article • Chemistry and Physics of Lipids, February 2010, Elsevier

    Dr. Martin M. Brandl

  46. Vesicular Phospholipid Gels

    Article • November 2009, Springer Science + Business Media

    Dr. Martin M. Brandl

  47. Asymmetric flow field-flow fractionation of liposomes: 2. Concentration detection and adsorptive loss phenomena

    Article • Journal of Separation Science, October 2009, Wiley

    Dr. Martin M. Brandl

  48. Altered Activity and Physicochemical Properties of Short Cationic Antimicrobial Peptides by Incorporation of Arginine Analogues

    Article • Molecular Pharmaceutics, June 2009, American Chemical Society (ACS)

    Dr. Martin M. Brandl

  49. Asymmetric flow field-flow fractionation of liposomes: optimization of fractionation variables

    Article • Journal of Separation Science, April 2009, Wiley

    Dr. Martin M. Brandl

  50. The Phospholipid Vesicle-Based Drug Permeability Assay: 5. Development Toward an Automated Procedure for High-Throughput Permeability Screening

    Article • JALA Journal of the Association for Laboratory Automation, February 2009, SAGE Publications

    Dr. Martin M. Brandl

  51. Drug permeability across a phospholipid vesicle-based barrier

    Article • European Journal of Pharmaceutical Sciences, July 2008, Elsevier

    Dr. Martin M. Brandl

  52. Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug–membrane interactions and the effect of agitation on the barrier integrity and on the permeability

    Article • European Journal of Pharmaceutical Sciences, March 2007, Elsevier

    Dr. Martin M. Brandl

  53. Vesicular Phospholipid Gels: A Technology Platform

    Article • Journal of Liposome Research, January 2007, Taylor & Francis

    Dr. Martin M. Brandl

  54. Liposome Size Analysis by Dynamic/Static Light Scattering upon Size Exclusion-/Field Flow-Fractionation

    Article • Journal of Nanoscience and Nanotechnology, September 2006, American Scientific Publishers

    Dr. Martin M. Brandl

  55. Drug permeability across a phospholipid vesicle-based barrier

    Article • European Journal of Pharmaceutical Sciences, July 2006, Elsevier

    Dr. Martin M. Brandl

  56. Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion

    Article • European Journal of Pharmaceutical Sciences, January 2006, Elsevier

    Dr. Martin M. Brandl

  57. Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix

    Article • European Journal of Pharmaceutics and Biopharmaceutics, April 2005, Elsevier

    Dr. Martin M. Brandl, Professor Ingunn Tho

  58. Camptothecin-catalyzed phospholipid hydrolysis in liposomes

    Article • International Journal of Pharmaceutics, January 2005, Elsevier

    Dr. Martin M. Brandl

  59. Effect of hydroxypropyl-?-cyclodextrin-complexation and pH on solubility of camptothecin

    Article • International Journal of Pharmaceutics, October 2004, Elsevier

    Dr. Martin M. Brandl

  60. Cytotoxic effect of different camptothecin formulations on human colon carcinoma in vitro

    Article • Anti-Cancer Drugs, October 2004, Wolters Kluwer Health

    Dr. Martin M. Brandl

  61. Development and validation of a HPLC method for routine quantification of the decapeptide Cetrorelix in liposome dispersions

    Article • Journal of Pharmaceutical and Biomedical Analysis, March 2004, Elsevier

    Dr. Martin M. Brandl

  62. Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface

    Article • European Journal of Pharmaceutical Sciences, February 2004, Elsevier

    Dr. Martin M. Brandl

  63. 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties

    Article • International Journal of Pharmaceutics, April 2003, Elsevier

    Dr. Martin M. Brandl

  64. Pharmacokinetics and antitumor activity of vincristine entrapped in vesicular phospholipid gels

    Article • Anti-Cancer Drugs, September 2002, Wolters Kluwer Health

    Dr. Martin M. Brandl

  65. Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels

    Article • Cancer Chemotherapy and Pharmacology, May 2002, Springer Science + Business Media

    Dr. Martin M. Brandl

  66. Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics

    Article • International Journal of Pharmaceutics, July 2001, Elsevier

    Dr. Martin M. Brandl

  67. Steam sterilisation of vesicular phospholipid gels

    Article • International Journal of Pharmaceutics, April 2001, Elsevier

    Dr. Martin M. Brandl

  68. Liposomes as drug carriers: a technological approach

    Article • January 2001, Elsevier

    Dr. Martin M. Brandl

  69. Effect of nucleoside analogues and oligonucleotides on hydrolysis of liposomal phospholipids

    Article • International Journal of Pharmaceutics, September 2000, Elsevier

    Dr. Martin M. Brandl

  70. Erosion and controlled release properties of semisolid vesicular phospholipid dispersions

    Article • Journal of Controlled Release, November 1998, Elsevier

    Dr. Martin M. Brandl

  71. Preparation and characterization of semi-solid phospholipid dispersions and dilutions thereof

    Article • International Journal of Pharmaceutics, August 1998, Elsevier

    Dr. Martin M. Brandl

  72. Morphology of semisolid aqueous phosphatidylcholine dispersions, a freeze fracture electron microscopy study

    Article • Chemistry and Physics of Lipids, May 1997, Elsevier

    Dr. Martin M. Brandl

  73. Biodistribution and Computed tomography Blood-Pool Imaging Properties of Polyethylene Glycol-Coated Iopromide-Carrying Liposomes

    Article • Investigative Radiology, January 1997, Wolters Kluwer Health

    Dr. Martin M. Brandl

  74. Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison

    Article • European Journal of Pharmaceutical Sciences, November 1996, Elsevier

    Dr. Martin M. Brandl

  75. Surface modification of continuously extruded contrast-carrying liposomes: Effect on their physical properties

    Article • International Journal of Pharmaceutics, April 1996, Elsevier

    Dr. Martin M. Brandl

  76. Generation of contrast-carrying liposomes of defined size with a new continuous high pressure extrusion method

    Article • International Journal of Pharmaceutics, April 1995, Elsevier

    Dr. Martin M. Brandl

  77. Detection of Lipopolysaccharides in Phospholipids and Liposomes Using the Limulus Test

    Article • Journal of Liposome Research, January 1995, Taylor & Francis

    Dr. Martin M. Brandl

  78. Acute toxicity and depression of phagocytosis in vivo by liposomes: Influence of lysophosphatidylcholine

    Article • Life Sciences, December 1994, Elsevier

    Dr. Martin M. Brandl

  79. Entrapment of haemoglobin into liposomes by the dehydration-rehydration method: vesicle characterization and in vivo behaviour

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, November 1994, Elsevier

    Dr. Martin M. Brandl

  80. Large-Scale Production of Liposomes of Defined size by a New Continuous High Pressure Extrusion Device

    Article • Drug Development and Industrial Pharmacy, January 1994, Taylor & Francis

    Dr. Martin M. Brandl

  81. Preparation of liposomes using a Mini-Lab 8.30 H high-pressure homogenizer

    Article • International Journal of Pharmaceutics, April 1993, Elsevier

    Dr. Martin M. Brandl

  82. Prozeßüberwachung und Automatisierung bei Hochleistungstablettenpressen

    Article • Pharmazie in unserer Zeit, January 1993, Wiley

    Dr. Martin M. Brandl

  83. Liposome Preparation by a New High Pressure Homogenizer Gaulin Micron Lab 40

    Article • Drug Development and Industrial Pharmacy, January 1990, Taylor & Francis

    Dr. Martin M. Brandl

  84. Hemoglobin-Liposomes as Blood Replacement Fluid

    Article • Drug Development and Industrial Pharmacy, January 1989, Taylor & Francis

    Dr. Martin M. Brandl